Imatinib vs Methotrexate
Imatinib vs Methotrexate: Overview
This comparison examines the pharmacological differences between Imatinib and Methotrexate.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Methotrexate: Dihydrofolate reductase inhibitor.
Pharmacokinetics
Half-life: Imatinib — 18 hours; Methotrexate — 3-10 hours.
Chemical Properties
Molecular Formula: Imatinib — C29H31N7O; Methotrexate — C20H22N8O5.
Molecular Weight: Imatinib — 493.6030 g/mol; Methotrexate — 454.4400 g/mol.
Type: Imatinib — Small molecule; Methotrexate — Small molecule.